Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

FINANCIAL INSTRUMENTS (Narrative) (Details)

v3.24.1
FINANCIAL INSTRUMENTS (Narrative) (Details)
€ in Thousands, ₪ in Thousands, $ in Thousands, $ in Thousands
 1 Months Ended 12 Months Ended
Nov. 29, 2022
CAD ($)
shares
Dec. 31, 2023
CAD ($)
Dec. 31, 2022
CAD ($)
Dec. 31, 2021
CAD ($)
Dec. 31, 2023
EUR (€)
Dec. 31, 2023
ILS (₪)
Dec. 31, 2023
USD ($)
Feb. 24, 2022
CAD ($)
Feb. 24, 2022
USD ($)
Disclosure of detailed information about financial instruments [line items]                  
Investments in unlisted shares measured at fair value   $ 2,285              
Fair value of the investments   2,285 $ 2,410            
Conversion of warrant and compensation options into common shares   0 $ 0 $ 611          
Xinteza Api Ltd [Member]                  
Disclosure of detailed information about financial instruments [line items]                  
Amount invested in exchange for additional future shares               $ 125 $ 100
Telekana [Member]                  
Disclosure of detailed information about financial instruments [line items]                  
Conversion of warrant and compensation options into common shares $ 611                
Number of ordinary shares issued upon conversion | shares 1,040                
Proportion Of Ownership Interests 51.00%                
Currency risk [Member] | EUR [Member] | Cash And Cash Equivalent [Member]                  
Disclosure of detailed information about financial instruments [line items]                  
Risk exposure associated with instruments sharing characteristic   407     € 278        
Currency risk [Member] | NIS [Member] | Cash And Cash Equivalent [Member]                  
Disclosure of detailed information about financial instruments [line items]                  
Risk exposure associated with instruments sharing characteristic   1,350       ₪ 3,698      
Currency risk [Member] | USD [Member] | Cash And Cash Equivalent [Member]                  
Disclosure of detailed information about financial instruments [line items]                  
Risk exposure associated with instruments sharing characteristic   $ 20         $ 15